In January 2022, the U.S. Food and Drug Administration (FDA) released finalized guidance on premarket pathways for combination products. While the guidance is not binding, it provides industry ...
US poised to ease restrictions on marijuana in historic shift, but it'll remain controlled substance
The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press has learned, a historic shift to generations of American drug policy that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results